Details of the Drug

General Information of Drug (ID: DMRJMDG)

Drug Name

DEDN-6526A

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01522664) A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma. U.S. National Institutes of Health.